Keymed Biosciences Inc. (2162.HK)

HKD 33.0

(-1.93%)

Revenue Summary of Keymed Biosciences Inc.

  • Keymed Biosciences Inc.'s latest annual revenue in 2023 was 354.09 Million CNY , up 253.87% from previous year.
  • Keymed Biosciences Inc.'s latest quarterly revenue in 2024 Q2 was 27.34 Million CNY , down 0.0% from previous quarter.
  • Keymed Biosciences Inc. reported a annual revenue of 100.06 Million CNY in annual revenue 2022, down -9.26% from previous year.
  • Keymed Biosciences Inc. reported a annual revenue of 110.26 Million CNY in annual revenue 2021, down 0.0% from previous year.
  • Keymed Biosciences Inc. reported a quarterly revenue of 27.34 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Keymed Biosciences Inc. reported a quarterly revenue of 13.48 Million CNY for 2023 Q3, down -91.76% from previous quarter.

Annual Revenue Chart of Keymed Biosciences Inc. (2023 - 2019)

Historical Annual Revenue of Keymed Biosciences Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 354.09 Million CNY 253.87%
2022 100.06 Million CNY -9.26%
2021 110.26 Million CNY 0.0%
2020 - CNY 0.0%
2019 - CNY 0.0%

Peer Revenue Comparison of Keymed Biosciences Inc.

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD 26.948%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 93.347%